|
|
iodine to particle ratio
|
carboxyl group to iodine ratio
|
nr of hydroxyl groups per molecule (directly related with
water solubility)
|
iodine content at 0.3 osm/kg H2O (mg/ml)
|
viscosity (37°C) (mPa . s) increases as the
iodine ratio increases
|
osmolality at 300 mg iodine/ml (osm/kg H2O)
|
osmo- toxicity decreases as the iodine ratio increases
|
chemo- toxicity = nr of carboxyl groups / nr of hydroxyl
groups
|
IV dose tolerance
|
| ionic monomers (high osmolality and chemotoxicity
: untoward haemodynamic and electro physiological effects resulting from
the presence of chelating agents) |
diatrizoate : sodium amidotrizoate + meglumine amidotrizoate
10:66 (Angiografin®, Gastrografin®, Urografin®
/ Uroselectan®, Renovist®, Renovist II®) |
3 : 2
|
1 : 3
|
0 (1 in ioxith.)
|
70-370
|
8.9
|
1.5-2.15
|
+++
|
+++
|
+
|
| iothalamate (Glofil®);
meglumine iothalamate (Biligrafin®) |
| ioxithalamate |
| iodamide (Renovue-65®, Renovue-DIP®) |
| metrizoate (Isopaque®) |
| ionic dimers |
ioxaglate (Hexabrix® 320) |
6 : 2
|
1 : 6
|
1
|
150
|
7.5
|
0.6
|
++
|
++
|
++
|
| nonionic monomers |
iomeprol (Imeron® 400) (without EDTA) |
3 : 1
|
0
|
4-6
|
150-450
|
8.6-10
|
0.6-0.7
|
++
|
0
|
++
|
| iobitridol (Xenetix® 250 or 350) |
| iopentol (Imagopaque®) |
| iopamidol (Iopamiron®, Solutrast®
370) |
| iopromide (Ultravist®) |
| iohexol (Omnipaque®) |
| ioversol (Optiray® 350) |
| ioxitol |
| metrizamide (Amipaque®) |
| nonionic dimers |
iotrolan (Iotrol®, Isovist®) |
6 : 1
|
0
|
9 or 12
|
300
|
11.4
|
0.29
|
+
|
0
|
++++
|
| iodixanol (Visipaque® 320) |